BCL2 and neuroblastoma: In this study, we compared the effects of selective BH3-mimetics in a panel of neuroblastoma cell lines and primary-derived cells, with the aim to assess which antiapoptotic BCL-2 protein is the most important therapeutic target in neuroblastoma.